|
IER3IP1 expression based on
|
KIRP : Kidney renal papillary cell carcinoma
| Comparison | Statistical significance |
| Normal-vs-Primary | 2.03080000038547E-07 |
|
KIRP : Kidney renal papillary cell carcinoma Note
Cancer stage information is not available for 89 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
3.30700000050754E-07 |
| Normal-vs-Stage2 |
4.952200E-02 |
| Normal-vs-Stage3 |
3.955600E-03 |
| Normal-vs-Stage4 |
1.461380E-01 |
| Stage1-vs-Stage2 |
3.944800E-01 |
| Stage1-vs-Stage3 |
9.830800E-01 |
| Stage1-vs-Stage4 |
7.730400E-01 |
| Stage2-vs-Stage3 |
5.684800E-01 |
| Stage2-vs-Stage4 |
8.160000E-01 |
| Stage3-vs-Stage4 |
8.464200E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient race information is not available for 15 samples and two samples from American Indians not included in the above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
3.56349999952599E-07 |
| Normal-vs-AfricanAmerican |
3.576000E-04 |
| Normal-vs-Asian |
1.334420E-02 |
| Caucasian-vs-AfricanAmerican |
6.568200E-01 |
| Caucasian-vs-Asian |
9.620600E-01 |
| AfricanAmerican-vs-Asian |
8.544400E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
4.6006999987469E-08 |
| Normal-vs-Female |
8.399500E-04 |
| Male-vs-Female |
6.204000E-02 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient BMI information is not available for 72 samples.
| Descriptions |
| Normal weight |
BMI greater than equal to 18.5 and BMI less than 25 |
Extereme weight |
BMI greater than equal to 25 and BMI less than 30 |
| Obese |
BMI greater than equal to 30 and BMI less than 40 |
Extreme Obese |
BMI greater than 40 |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Normal_Weight |
4.957300E-03 |
| Normal-vs-Extreme_Weight |
5.37499999953006E-07 |
| Normal-vs-Obese |
5.5521999999919E-05 |
| Normal-vs-Extreme_Obese |
4.285200E-01 |
| Normal_Weight-vs-Extreme_Weight |
1.662030E-01 |
| Normal_Weight-vs-Obese |
4.183800E-01 |
| Normal_Weight-vs-Extreme_Obese |
5.078400E-01 |
| Extreme_Weight-vs-Obese |
5.551400E-01 |
| Extreme_Weight-vs-Extreme_Obese |
1.293980E-01 |
| Obese-vs-Extreme_Obese |
2.387200E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient age information is not available for 3 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
5.85009999999331E-05 |
| Normal-vs-Age(41-60Yrs) |
7.77950000000471E-05 |
| Normal-vs-Age(61-80Yrs) |
6.24339999699686E-08 |
| Normal-vs-Age(81-100Yrs) |
3.381800E-03 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
2.798200E-01 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
9.623000E-01 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
6.905000E-01 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
1.606610E-01 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
7.944600E-01 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
7.135400E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma NOTE
Histology information is not available for 17 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-VS-Type1 PRCC |
9.06390000054991E-07 |
| Normal-VS-Type2 PRCC |
2.403900E-03 |
| Normal-VS-KIRP CIMP |
2.164400E-01 |
| Normal-VS-Unclassified PRCC |
1.25130000028228E-07 |
| Type1 PRCC-VS-Type2 PRCC |
2.960600E-01 |
| Type1 PRCC-VS-KIRP CIMP |
2.498600E-01 |
| Type1 PRCC-VS-Unclassified PRCC |
1.688210E-01 |
| Type2 PRCC-VS-KIRP CIMP |
7.468000E-01 |
| Type2 PRCC-VS-Unclassified PRCC |
5.597900E-02 |
| KIRP CIMP-VS-Unclassified PRCC |
7.968000E-02 |
|
Histologic PRCC subtypes: Ricketts CJ et al, The Cancer Genome Atlas Comprehensive Molecular Characterization of Renal Cell Carcinoma. Cell Rep. 2018 Apr 3;23(1):313-326.e5. doi: 10.1016/j.celrep.2018.03.075
|
KIRP : Kidney renal papillary cell carcinoma Note
Nodal metastais status is not available for 1 sample and cancer in nearby lymph nodes cannot be measured (NX) in 211 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
3.264700E-03 |
| Normal-vs-N1 |
1.878180E-03 |
| Normal-vs-N2 |
5.944000E-01 |
| N0-vs-N1 |
4.129200E-01 |
| N0-vs-N2 |
8.053400E-01 |
| N1-vs-N2 |
5.349200E-01 |
|
|
